Technology43m ago
Mithrl Raises $20M to Speed Drug R&D With AI—Token Efficiency Is the Real Story
The biotech AI startup's Series A backs a platform that cuts computational overhead by 45 percent, positioning it as infrastructure for pharma's discovery bottleneck.